BUFSX | VSGAX | BUFSX / VSGAX | |
Total Expense Ratio | 0.97 | 0.07 | 1,386% |
Annual Report Gross Expense Ratio | 0.97 | 0.07 | 1,386% |
Fund Existence | 27 years | 14 years | - |
Gain YTD | -0.941 | 0.619 | -152% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 519M | 35B | 1% |
Annual Yield % from dividends | 0.00 | 0.54 | - |
Returns for 1 year | 6.27 | 12.95 | 48% |
Returns for 3 years | 11.92 | 41.87 | 28% |
Returns for 5 years | -6.83 | 40.75 | -17% |
Returns for 10 years | -55.02 | 116.41 | -47% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPLG | 73.57 | 0.92 | +1.27% |
SPDR® Portfolio S&P 500® ETF | |||
RPHS | 10.58 | 0.09 | +0.81% |
Regents Park Hedged Market Strategy ETF | |||
MXI | 87.67 | -0.15 | -0.17% |
iShares Global Materials ETF | |||
VCEB | 63.04 | -0.12 | -0.20% |
Vanguard ESG US Corporate Bond ETF | |||
BIS | 16.74 | -0.15 | -0.89% |
ProShares UltraShort Nasdaq Biotech |